Samsung Bioepis announces 10-year SB12 supply deal for Brazil’s public health system
The company says it will supply the rare disease biosimilar from 2027 under a Brazilian program that also calls for technology transfer to local partners.
Topic
Samsung Bioepis
The latest NewsJaws reporting on Samsung Bioepis: developments, background and what happens next, with every source linked.
1 NewsJaws report, latest
1 story